Onkologie. 2016:10(3):135-137 | DOI: 10.36290/xon.2016.029

Treatment of cancer in pregnancy

Vít Drochýtek, Lukáš Rob, Michael J.Halaška
Gynekologicko-porodnická klinika 2. LF UK a FN v Motole, Praha

With the social trend towards older motherhood, the incidence of cancer diagnosed during pregnancy increases. Oncological

prognosis of such patients is no different from the non-pregnant patients diagnosed with cancer. Thanks to the current level of

knowledge, many patients are offered the possibility to continue with the pregnancy with concurrent oncological treatment.

This article summarizes the basic facts regarding diagnostics and treatment of cancer in pregnancy, including administration of

chemotherapy.

Keywords: cervical carcinoma, ovarian cancer, chemotherapy, prognosis

Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drochýtek V, Rob L, Halaška MJ. Treatment of cancer in pregnancy. Onkologie. 2016;10(3):135-137. doi: 10.36290/xon.2016.029.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. EUROSTAT - Live births by mother's age and birth order. http://ec europa eu/eurostat/web/population-demography-migration-projections/births-fertitily-data/database 2015.
    2. Halaska M jr, Rob L. Epidemiologie malignit diagnostikovaných v těhotenství. Onkologická onemocnění během těhotenství. Praha: Mladá fronta; 2015: 14-9.
    3. Eibye S, Kjaer SK, Mellemkjaer L. Incidence of pregnancy-associated cancer in Denmark, 1977-2006. Obstet Gynecol 2013 Sep; 122(3): 608-617. Go to original source...
    4. Lee YY, Roberts CL, Dobbins T, Stavrou E, Black K, Morris J, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study. BJOG 2012 Dec; 119(13): 1572-1582. Go to original source...
    5. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003 Oct; 189(4): 1128-1135. Go to original source...
    6. Shin DS, Poder L, Courtier J, Naeger DM, Westphalen AC, Coakley FV. CT and MRI of early intrauterine pregnancy. AJR Am J Roentgenol 2011 Feb; 196(2): 325-330. Go to original source... Go to PubMed...
    7. Thomsen HS, Morcos SK, Almen T, Bellin MF, Bertolotto M, Bongartz G, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2013 Feb; 23(2): 307-318. Go to original source...
    8. Zanotti-Fregonara P, Champion C, Trebossen R, Maroy R, Devaux JY, Hindie E. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med 2008 Apr; 49(4): 679-682. Go to original source... Go to PubMed...
    9. Amant F, Van CK, Halaska MJ, Beijnen J, Lagae L, Hanssens M, et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer 2009 May; 19(Suppl 1): S1-12. Go to original source...
    10. Gentilini O, Cremonesi M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004; 15: 1348-1351. Go to original source...
    11. Keleher A, Wendt R, Delpassand E, Stachowiak AM, Kuerer HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 2004 Nov; 10(6): 492-495. Go to original source... Go to PubMed...
    12. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001 Oct; 182(4): 393-398. Go to original source... Go to PubMed...
    13. Sharp C, Shrimpton J A, Bury RF. Advice on exposure to ionising radiation during pregnancy: diagnostic medical exposures. National Radiological Protection Board; 1998.
    14. Amant F, Van CK, Halaska MJ, Gziri MM, Hui W, Lagae L, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 2012 Mar; 13(3): 256-264. Go to original source...
    15. Tharmaratnam U, Balki M. Anesthetic management during labor and delivery: a 21-year review of women with cancer in a tertiary care center. J Clin Anesth 2012 Nov; 24(7): 524-530. Go to original source...
    16. Pearl J, Price R, Richardson W, Fanelli R. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Surg Endosc 2011 Nov; 25(11): 3479-3492. Go to original source... Go to PubMed...
    17. Cohen-Kerem R, Railton C, Oren D, Lishner M, Koren G. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 2005 Sep; 190(3): 467-473. Go to original source... Go to PubMed...
    18. Grimm D, Woelber L, Trillsch F, Amsberg G, Mahner S. Clinical management of epithelial ovarian cancer during pregnancy. Eur J Cancer 2014 Mar; 50(5): 963-971. Go to original source...
    19. Vercellino GF, Koehler C, Erdemoglu E, Mangler M, Lanowska M, Malak AH, et al. Laparoscopic pelvic lymphadenectomy in 32 pregnant patients with cervical cancer: rationale, description of the technique, and outcome. Int J Gynecol Cancer 2014 Feb; 24(2): 364-371. Go to original source...
    20. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005 May; 6(5): 328-333. Go to original source...
    21. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol 1997 Feb; 70: 130-139. Go to original source...
    22. Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol 2004 Jun; 44(3): 191-196. Go to original source...
    23. van Calsteren K, Verbesselt R, Ottevanger N, Halaska M, Heyns L, Van BR, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand 2010 Oct; 89(10): 1338-1345. Go to original source... Go to PubMed...
    24. Amant F, Halaska MJ, Fumagalli M, Dahl SK, Lok C, Van CK, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014 Mar; 24(3): 394-403. Go to original source...
    25. van Calsteren K, Verbesselt R, Devlieger R, De CL, Chai DC, Van BR, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer 2010 Dec; 20(9): 1456-1464. Go to PubMed...
    26. Weisz B, Schiff E, Lishner M. Cancer in pregnancy: maternal and fetal implications. Hum Reprod Update 2001 Jul; 7(4): 384-393. Go to original source... Go to PubMed...
    27. Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010 Jan; 16(1): 76-82. Go to original source... Go to PubMed...
    28. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001 Dec; 2(3): 173-177. Go to original source... Go to PubMed...
    29. Cardonick EH, Gringlas MB, Hunter K, Greenspan J. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. Am J Obstet Gynecol 2015 May; 212(5): 658. Go to original source...
    30. Halaska MJ, Komar M, Vlk R, Tomek V, Skultety J, Robova H, et al. A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy. Eur J Obstet Gynecol Reprod Biol 2014 Mar; 174: 76-79. Go to original source...
    31. Pasternak B, Svanstrom H, Molgaard-Nielsen D, Melbye M, Hviid A. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA 2013 Oct 16; 310(15): 1601-1611. Go to original source... Go to PubMed...
    32. Pasternak B, Svanstrom H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med 2013 Feb 28; 368(9): 814-823. Go to original source...
    33. Tan PC, Omar SZ. Contemporary approaches to hyperemesis during pregnancy. Curr Opin Obstet Gynecol 2011 Apr; 23(2): 87-93. Go to original source...
    34. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 2009 Nov; 24(11): 2703-2708. Go to original source...
    35. Sienas L, Wong T, Collins R, Smith J. Contemporary uses of erythropoietin in pregnancy: a literature review. Obstet Gynecol Surv 2013 Aug; 68(8): 594-602. Go to original source...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.